Mastitis: II. Evaluation of Antimicrobial Amines for Use as Teat Dips

Recent proposals by the Food and Drug Administration to regulate teat dips as drugs have led to a search for safer teat dip ingredients. Primary, secondary, and tertiary alkyl amines (carbon-10 to −18 chain length) inhibit growth of mastitic bacteria (Streptococcus agalactiae, Streptococcus uberis,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of dairy science 1980-01, Vol.63 (1), p.95-100
Hauptverfasser: Culler, M.D., Bitman, Joel, Turck, P.A., Schultze, W.D., Thompson, M.J., Robbins, W.E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 100
container_issue 1
container_start_page 95
container_title Journal of dairy science
container_volume 63
creator Culler, M.D.
Bitman, Joel
Turck, P.A.
Schultze, W.D.
Thompson, M.J.
Robbins, W.E.
description Recent proposals by the Food and Drug Administration to regulate teat dips as drugs have led to a search for safer teat dip ingredients. Primary, secondary, and tertiary alkyl amines (carbon-10 to −18 chain length) inhibit growth of mastitic bacteria (Streptococcus agalactiae, Streptococcus uberis, Staphylococcus aureus, Escherichi coli, Klebsiella pneumoniae) in a broth tube culture assay. Since carbon-13 compounds were active, a carbon-13 primary (tridecanamine hydrochloride), secondary methyl (N-methyltridecanamine), secondary ethyl (N-ethyltridecanamine), tertiary dimethyl amine (N, N-dimethyltridecanamine), and carbon-12 quaternary amine (N, N, -trimethyl-dodecaneammonium chloride) were tested for their ability to reduce experimentally applied populations of S. agalactiae or E. coli on the bovine teat surface. The five compounds were compared at concentrations of 100, 500, 1,000, 3,000, 7,000, and 10,000ppm. Activity was greater against the gram-positive S. agalactiae than against the gram-negative E. coli. The tertiary amine was most active, producing a log reduction of 4 (reduction of bacterial number from 106 to 102) at a concentration of 3,000ppm in the teat dip. The relative order of effectiveness for the amines was:, dimethyl tertiary > methyl secondary > ethyl secondary > primary = quaternary. The results suggest that these amines may be useful as potent, effective antibacterial agents for incorporation into teat dips.
doi_str_mv 10.3168/jds.S0022-0302(80)82893-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75106708</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022030280828931</els_id><sourcerecordid>1839958064</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4181-a0a9bc84ecb3f7caf77f8f19ffc52207e0a08c33dde384080e688201a2c76dc33</originalsourceid><addsrcrecordid>eNqNkcFuEzEQhi0EKmnhEUBGIASHDWNv1jvmFoUAkYo4tDlbjtduHe2uU3u3qG-P04164MTJsuab3zOfCXnHYF4ygV_2TZpfAXBeQAn8E8Jn5CjLgj0jM1bxqiiZxOdk9oS8JOcp7fOVcajOyJmQKFGIGVn_0mnwg09f6WYzp-t73Y568KGnwdFlP_jOmxh2Xrd02fneJupCpNtkqU702uqBfvOH9Iq8cLpN9vXpvCDb7-vr1c_i8vePzWp5WZgFQ1Zo0HJncGHNrnS10a6uHTomnTMV51Bb0ICmLJvGlrgABCsQOTDNTS2aXLggH6fcQwx3o02D6nwytm11b8OYVF0xEDVgBt__A-7DGPs8m2JYSlkhiEWm5ETlFVOK1qlD9J2OD4qBOopWWbR6FK2OFhWCehStWO59c3ph3HW2eeo8mc31D1P91t_c_vHRqtTpts00O6aKnKFklbG3E-Z0UPom-qS2V_nz8h6cCXlceTUBNnu99zaqZLztjW1yphlUE_x_TPsXvRGjwA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1839958064</pqid></control><display><type>article</type><title>Mastitis: II. Evaluation of Antimicrobial Amines for Use as Teat Dips</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Periodicals Index Online</source><creator>Culler, M.D. ; Bitman, Joel ; Turck, P.A. ; Schultze, W.D. ; Thompson, M.J. ; Robbins, W.E.</creator><creatorcontrib>Culler, M.D. ; Bitman, Joel ; Turck, P.A. ; Schultze, W.D. ; Thompson, M.J. ; Robbins, W.E.</creatorcontrib><description>Recent proposals by the Food and Drug Administration to regulate teat dips as drugs have led to a search for safer teat dip ingredients. Primary, secondary, and tertiary alkyl amines (carbon-10 to −18 chain length) inhibit growth of mastitic bacteria (Streptococcus agalactiae, Streptococcus uberis, Staphylococcus aureus, Escherichi coli, Klebsiella pneumoniae) in a broth tube culture assay. Since carbon-13 compounds were active, a carbon-13 primary (tridecanamine hydrochloride), secondary methyl (N-methyltridecanamine), secondary ethyl (N-ethyltridecanamine), tertiary dimethyl amine (N, N-dimethyltridecanamine), and carbon-12 quaternary amine (N, N, -trimethyl-dodecaneammonium chloride) were tested for their ability to reduce experimentally applied populations of S. agalactiae or E. coli on the bovine teat surface. The five compounds were compared at concentrations of 100, 500, 1,000, 3,000, 7,000, and 10,000ppm. Activity was greater against the gram-positive S. agalactiae than against the gram-negative E. coli. The tertiary amine was most active, producing a log reduction of 4 (reduction of bacterial number from 106 to 102) at a concentration of 3,000ppm in the teat dip. The relative order of effectiveness for the amines was:, dimethyl tertiary &gt; methyl secondary &gt; ethyl secondary &gt; primary = quaternary. The results suggest that these amines may be useful as potent, effective antibacterial agents for incorporation into teat dips.</description><identifier>ISSN: 0022-0302</identifier><identifier>EISSN: 1525-3198</identifier><identifier>DOI: 10.3168/jds.S0022-0302(80)82893-1</identifier><identifier>PMID: 6989866</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Amines - therapeutic use ; Animals ; Cattle ; Cattle Diseases - drug therapy ; Drug Evaluation ; Escherichia coli Infections - drug therapy ; Escherichia coli Infections - veterinary ; Female ; Klebsiella Infections - drug therapy ; Klebsiella Infections - veterinary ; Mastitis, Bovine - drug therapy ; Staphylococcal Infections - drug therapy ; Staphylococcal Infections - veterinary ; Structure-Activity Relationship</subject><ispartof>Journal of dairy science, 1980-01, Vol.63 (1), p.95-100</ispartof><rights>1980 American Dairy Science Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4181-a0a9bc84ecb3f7caf77f8f19ffc52207e0a08c33dde384080e688201a2c76dc33</citedby><cites>FETCH-LOGICAL-c4181-a0a9bc84ecb3f7caf77f8f19ffc52207e0a08c33dde384080e688201a2c76dc33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022030280828931$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,4010,27846,27900,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6989866$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Culler, M.D.</creatorcontrib><creatorcontrib>Bitman, Joel</creatorcontrib><creatorcontrib>Turck, P.A.</creatorcontrib><creatorcontrib>Schultze, W.D.</creatorcontrib><creatorcontrib>Thompson, M.J.</creatorcontrib><creatorcontrib>Robbins, W.E.</creatorcontrib><title>Mastitis: II. Evaluation of Antimicrobial Amines for Use as Teat Dips</title><title>Journal of dairy science</title><addtitle>J Dairy Sci</addtitle><description>Recent proposals by the Food and Drug Administration to regulate teat dips as drugs have led to a search for safer teat dip ingredients. Primary, secondary, and tertiary alkyl amines (carbon-10 to −18 chain length) inhibit growth of mastitic bacteria (Streptococcus agalactiae, Streptococcus uberis, Staphylococcus aureus, Escherichi coli, Klebsiella pneumoniae) in a broth tube culture assay. Since carbon-13 compounds were active, a carbon-13 primary (tridecanamine hydrochloride), secondary methyl (N-methyltridecanamine), secondary ethyl (N-ethyltridecanamine), tertiary dimethyl amine (N, N-dimethyltridecanamine), and carbon-12 quaternary amine (N, N, -trimethyl-dodecaneammonium chloride) were tested for their ability to reduce experimentally applied populations of S. agalactiae or E. coli on the bovine teat surface. The five compounds were compared at concentrations of 100, 500, 1,000, 3,000, 7,000, and 10,000ppm. Activity was greater against the gram-positive S. agalactiae than against the gram-negative E. coli. The tertiary amine was most active, producing a log reduction of 4 (reduction of bacterial number from 106 to 102) at a concentration of 3,000ppm in the teat dip. The relative order of effectiveness for the amines was:, dimethyl tertiary &gt; methyl secondary &gt; ethyl secondary &gt; primary = quaternary. The results suggest that these amines may be useful as potent, effective antibacterial agents for incorporation into teat dips.</description><subject>Amines - therapeutic use</subject><subject>Animals</subject><subject>Cattle</subject><subject>Cattle Diseases - drug therapy</subject><subject>Drug Evaluation</subject><subject>Escherichia coli Infections - drug therapy</subject><subject>Escherichia coli Infections - veterinary</subject><subject>Female</subject><subject>Klebsiella Infections - drug therapy</subject><subject>Klebsiella Infections - veterinary</subject><subject>Mastitis, Bovine - drug therapy</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcal Infections - veterinary</subject><subject>Structure-Activity Relationship</subject><issn>0022-0302</issn><issn>1525-3198</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1980</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>K30</sourceid><recordid>eNqNkcFuEzEQhi0EKmnhEUBGIASHDWNv1jvmFoUAkYo4tDlbjtduHe2uU3u3qG-P04164MTJsuab3zOfCXnHYF4ygV_2TZpfAXBeQAn8E8Jn5CjLgj0jM1bxqiiZxOdk9oS8JOcp7fOVcajOyJmQKFGIGVn_0mnwg09f6WYzp-t73Y568KGnwdFlP_jOmxh2Xrd02fneJupCpNtkqU702uqBfvOH9Iq8cLpN9vXpvCDb7-vr1c_i8vePzWp5WZgFQ1Zo0HJncGHNrnS10a6uHTomnTMV51Bb0ICmLJvGlrgABCsQOTDNTS2aXLggH6fcQwx3o02D6nwytm11b8OYVF0xEDVgBt__A-7DGPs8m2JYSlkhiEWm5ETlFVOK1qlD9J2OD4qBOopWWbR6FK2OFhWCehStWO59c3ph3HW2eeo8mc31D1P91t_c_vHRqtTpts00O6aKnKFklbG3E-Z0UPom-qS2V_nz8h6cCXlceTUBNnu99zaqZLztjW1yphlUE_x_TPsXvRGjwA</recordid><startdate>198001</startdate><enddate>198001</enddate><creator>Culler, M.D.</creator><creator>Bitman, Joel</creator><creator>Turck, P.A.</creator><creator>Schultze, W.D.</creator><creator>Thompson, M.J.</creator><creator>Robbins, W.E.</creator><general>Elsevier Inc</general><general>Am Dairy Sci Assoc</general><general>American Dairy Science Association</general><scope>6I.</scope><scope>AAFTH</scope><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7WH</scope><scope>K30</scope><scope>PAAUG</scope><scope>PAWHS</scope><scope>PAWZZ</scope><scope>PAXOH</scope><scope>PBHAV</scope><scope>PBQSW</scope><scope>PBYQZ</scope><scope>PCIWU</scope><scope>PCMID</scope><scope>PCZJX</scope><scope>PDGRG</scope><scope>PDWWI</scope><scope>PETMR</scope><scope>PFVGT</scope><scope>PGXDX</scope><scope>PIHIL</scope><scope>PISVA</scope><scope>PJCTQ</scope><scope>PJTMS</scope><scope>PLCHJ</scope><scope>PMHAD</scope><scope>PNQDJ</scope><scope>POUND</scope><scope>PPLAD</scope><scope>PQAPC</scope><scope>PQCAN</scope><scope>PQCMW</scope><scope>PQEME</scope><scope>PQHKH</scope><scope>PQMID</scope><scope>PQNCT</scope><scope>PQNET</scope><scope>PQSCT</scope><scope>PQSET</scope><scope>PSVJG</scope><scope>PVMQY</scope><scope>PZGFC</scope><scope>7X8</scope></search><sort><creationdate>198001</creationdate><title>Mastitis: II. Evaluation of Antimicrobial Amines for Use as Teat Dips</title><author>Culler, M.D. ; Bitman, Joel ; Turck, P.A. ; Schultze, W.D. ; Thompson, M.J. ; Robbins, W.E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4181-a0a9bc84ecb3f7caf77f8f19ffc52207e0a08c33dde384080e688201a2c76dc33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1980</creationdate><topic>Amines - therapeutic use</topic><topic>Animals</topic><topic>Cattle</topic><topic>Cattle Diseases - drug therapy</topic><topic>Drug Evaluation</topic><topic>Escherichia coli Infections - drug therapy</topic><topic>Escherichia coli Infections - veterinary</topic><topic>Female</topic><topic>Klebsiella Infections - drug therapy</topic><topic>Klebsiella Infections - veterinary</topic><topic>Mastitis, Bovine - drug therapy</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcal Infections - veterinary</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Culler, M.D.</creatorcontrib><creatorcontrib>Bitman, Joel</creatorcontrib><creatorcontrib>Turck, P.A.</creatorcontrib><creatorcontrib>Schultze, W.D.</creatorcontrib><creatorcontrib>Thompson, M.J.</creatorcontrib><creatorcontrib>Robbins, W.E.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Periodicals Index Online Segment 50</collection><collection>Periodicals Index Online</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - West</collection><collection>Primary Sources Access (Plan D) - International</collection><collection>Primary Sources Access &amp; Build (Plan A) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Midwest</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Northeast</collection><collection>Primary Sources Access (Plan D) - Southeast</collection><collection>Primary Sources Access (Plan D) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Southeast</collection><collection>Primary Sources Access (Plan D) - South Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - UK / I</collection><collection>Primary Sources Access (Plan D) - Canada</collection><collection>Primary Sources Access (Plan D) - EMEALA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - South Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - International</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - International</collection><collection>Primary Sources Access (Plan D) - West</collection><collection>Periodicals Index Online Segments 1-50</collection><collection>Primary Sources Access (Plan D) - APAC</collection><collection>Primary Sources Access (Plan D) - Midwest</collection><collection>Primary Sources Access (Plan D) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Canada</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - EMEALA</collection><collection>Primary Sources Access &amp; Build (Plan A) - APAC</collection><collection>Primary Sources Access &amp; Build (Plan A) - Canada</collection><collection>Primary Sources Access &amp; Build (Plan A) - West</collection><collection>Primary Sources Access &amp; Build (Plan A) - EMEALA</collection><collection>Primary Sources Access (Plan D) - Northeast</collection><collection>Primary Sources Access &amp; Build (Plan A) - Midwest</collection><collection>Primary Sources Access &amp; Build (Plan A) - North Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - Northeast</collection><collection>Primary Sources Access &amp; Build (Plan A) - South Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - Southeast</collection><collection>Primary Sources Access (Plan D) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - APAC</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - MEA</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of dairy science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Culler, M.D.</au><au>Bitman, Joel</au><au>Turck, P.A.</au><au>Schultze, W.D.</au><au>Thompson, M.J.</au><au>Robbins, W.E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mastitis: II. Evaluation of Antimicrobial Amines for Use as Teat Dips</atitle><jtitle>Journal of dairy science</jtitle><addtitle>J Dairy Sci</addtitle><date>1980-01</date><risdate>1980</risdate><volume>63</volume><issue>1</issue><spage>95</spage><epage>100</epage><pages>95-100</pages><issn>0022-0302</issn><eissn>1525-3198</eissn><abstract>Recent proposals by the Food and Drug Administration to regulate teat dips as drugs have led to a search for safer teat dip ingredients. Primary, secondary, and tertiary alkyl amines (carbon-10 to −18 chain length) inhibit growth of mastitic bacteria (Streptococcus agalactiae, Streptococcus uberis, Staphylococcus aureus, Escherichi coli, Klebsiella pneumoniae) in a broth tube culture assay. Since carbon-13 compounds were active, a carbon-13 primary (tridecanamine hydrochloride), secondary methyl (N-methyltridecanamine), secondary ethyl (N-ethyltridecanamine), tertiary dimethyl amine (N, N-dimethyltridecanamine), and carbon-12 quaternary amine (N, N, -trimethyl-dodecaneammonium chloride) were tested for their ability to reduce experimentally applied populations of S. agalactiae or E. coli on the bovine teat surface. The five compounds were compared at concentrations of 100, 500, 1,000, 3,000, 7,000, and 10,000ppm. Activity was greater against the gram-positive S. agalactiae than against the gram-negative E. coli. The tertiary amine was most active, producing a log reduction of 4 (reduction of bacterial number from 106 to 102) at a concentration of 3,000ppm in the teat dip. The relative order of effectiveness for the amines was:, dimethyl tertiary &gt; methyl secondary &gt; ethyl secondary &gt; primary = quaternary. The results suggest that these amines may be useful as potent, effective antibacterial agents for incorporation into teat dips.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>6989866</pmid><doi>10.3168/jds.S0022-0302(80)82893-1</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-0302
ispartof Journal of dairy science, 1980-01, Vol.63 (1), p.95-100
issn 0022-0302
1525-3198
language eng
recordid cdi_proquest_miscellaneous_75106708
source MEDLINE; ScienceDirect Journals (5 years ago - present); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Periodicals Index Online
subjects Amines - therapeutic use
Animals
Cattle
Cattle Diseases - drug therapy
Drug Evaluation
Escherichia coli Infections - drug therapy
Escherichia coli Infections - veterinary
Female
Klebsiella Infections - drug therapy
Klebsiella Infections - veterinary
Mastitis, Bovine - drug therapy
Staphylococcal Infections - drug therapy
Staphylococcal Infections - veterinary
Structure-Activity Relationship
title Mastitis: II. Evaluation of Antimicrobial Amines for Use as Teat Dips
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T19%3A10%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mastitis:%20II.%20Evaluation%20of%20Antimicrobial%20Amines%20for%20Use%20as%20Teat%20Dips&rft.jtitle=Journal%20of%20dairy%20science&rft.au=Culler,%20M.D.&rft.date=1980-01&rft.volume=63&rft.issue=1&rft.spage=95&rft.epage=100&rft.pages=95-100&rft.issn=0022-0302&rft.eissn=1525-3198&rft_id=info:doi/10.3168/jds.S0022-0302(80)82893-1&rft_dat=%3Cproquest_cross%3E1839958064%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1839958064&rft_id=info:pmid/6989866&rft_els_id=S0022030280828931&rfr_iscdi=true